Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael T Heneka

Showing results (71-80 of 313) with videos related to

Pageof 32
Sort By:
Journal of Alzheimer'S Disease : JAD|October 16, 2025
Can vigorous physical activity mitigate the effect of systemic inflammation on cognitive performance? Results from a large older community dwelling population in The NetherlandsAnne Fink, Constantin Reinke, Benjamin Aretz, et al.
Nature Reviews. Neurology|March 11, 2020
Do infections have a role in the pathogenesis of Alzheimer disease?Ruth F Itzhaki, Todd E Golde, Michael T Heneka, et al.
Cellular and Molecular Neurobiology|September 30, 2003
Intrinsic regulation of brain inflammatory responsesElena Galea, Michael T Heneka, Cinzia Dello Russo, et al.
Journal of Neuroimmunology|November 5, 2003
Interleukin-1 beta and lipopolysaccharide decrease soluble guanylyl cyclase in brain cells: NO-independent destabilization of protein and NO-dependent decrease of mRNACarlos E Pedraza, María Antonia Baltrons, Michael T Heneka, et al.
Current Neuropharmacology|June 2, 2012
Impact and Therapeutic Potential of PPARs in Alzheimer's DiseaseMichael T Heneka, Elisabet Reyes-Irisarri, Michael Hüll, et al.
Journal of Alzheimer'S Disease : JAD|May 14, 2023
Sporadic Use of Antibiotics in Older Adults and the Risk of Dementia: A Nested Case-Control Study Based on German Health Claims DataElena Rakuša, Anne Fink, Gültekin Tamgüney, et al.
Alzheimer'S Research & Therapy|June 6, 2020
Immediate and long-term consequences of COVID-19 infections for the development of neurological diseaseMichael T Heneka, Douglas Golenbock, Eicke Latz, et al.
Nature Reviews. Neurology|September 15, 2021
Peripheral and central immune system crosstalk in Alzheimer disease - a research prospectusBrianne M Bettcher, Malú G Tansey, Guillaume Dorothée, et al.
Neurobiology of Disease|July 20, 2002
Beta-amyloid peptides decrease soluble guanylyl cyclase expression in astroglial cellsMaría Antonia Baltrons, Carlos E Pedraza, Michael T Heneka, et al.
Journal of Neurology|July 24, 2012
Long-term neuromuscular sequelae of critical illnessAlexander Semmler, Torsten Okulla, Markus Kaiser, et al.
Pageof 32

Showing results (71-80 of 313) with videos related to

Sort By:
Pageof 32
Journal of Alzheimer'S Disease : JAD|October 16, 2025
Can vigorous physical activity mitigate the effect of systemic inflammation on cognitive performance? Results from a large older community dwelling population in The NetherlandsAnne Fink, Constantin Reinke, Benjamin Aretz, et al.
Nature Reviews. Neurology|March 11, 2020
Do infections have a role in the pathogenesis of Alzheimer disease?Ruth F Itzhaki, Todd E Golde, Michael T Heneka, et al.
Cellular and Molecular Neurobiology|September 30, 2003
Intrinsic regulation of brain inflammatory responsesElena Galea, Michael T Heneka, Cinzia Dello Russo, et al.
Journal of Neuroimmunology|November 5, 2003
Interleukin-1 beta and lipopolysaccharide decrease soluble guanylyl cyclase in brain cells: NO-independent destabilization of protein and NO-dependent decrease of mRNACarlos E Pedraza, María Antonia Baltrons, Michael T Heneka, et al.
Current Neuropharmacology|June 2, 2012
Impact and Therapeutic Potential of PPARs in Alzheimer's DiseaseMichael T Heneka, Elisabet Reyes-Irisarri, Michael Hüll, et al.
Journal of Alzheimer'S Disease : JAD|May 14, 2023
Sporadic Use of Antibiotics in Older Adults and the Risk of Dementia: A Nested Case-Control Study Based on German Health Claims DataElena Rakuša, Anne Fink, Gültekin Tamgüney, et al.
Alzheimer'S Research & Therapy|June 6, 2020
Immediate and long-term consequences of COVID-19 infections for the development of neurological diseaseMichael T Heneka, Douglas Golenbock, Eicke Latz, et al.
Nature Reviews. Neurology|September 15, 2021
Peripheral and central immune system crosstalk in Alzheimer disease - a research prospectusBrianne M Bettcher, Malú G Tansey, Guillaume Dorothée, et al.
Neurobiology of Disease|July 20, 2002
Beta-amyloid peptides decrease soluble guanylyl cyclase expression in astroglial cellsMaría Antonia Baltrons, Carlos E Pedraza, Michael T Heneka, et al.
Journal of Neurology|July 24, 2012
Long-term neuromuscular sequelae of critical illnessAlexander Semmler, Torsten Okulla, Markus Kaiser, et al.
Pageof 32